Primary record
CHIR-99021|||6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile
- 库存
- 9,134 克
- 纯度
- 99.7 %
- CAS
- 252917-06-9
化合物标识与属性
- CAS
- 252917-06-9
- PubChem CID
- 9956119
- SMILES
- CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N
- Canonical SMILES
- Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1
名称与同义词
- laduviglusib
- CHIR-99021
- 252917-06-9
- CHIR99021
- CHIR 99021
- Laduviglusib [USAN]
- Laduviglusib (GMP)
- GSK-3 Inhibitor XVI
- CHIR-911
- CT99021
- CT-99021
- Laduviglusib (USAN)
- Kinome_3785
- LADUVIGLUSIB [INN]
- Laduviglusib (Standard)
- RefChem:798393
- 234CMT4GK4
- CHIR 911
- FX03
- UNII-234CMT4GK4
- cc-59
- D0YK9D
- CHR00921
- C22H18Cl2N8
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N
- CHEMBL412142
- CT 99021
- MFCD11846251
- CHEBI:91091
- SCHEMBL151139
- SCHEMBL240280
- DTXSID90179931
- CHR-00921
- GTPL8014
- orb1305728
- TB4423-GMP
- SCHEMBL29351682
- SCHEMBL29353709
- SCHEMBL29359162
- SCHEMBL29381114
- SCHEMBL29838591
- CTK4F5391
- KS-00000XOW
- 252917-06-9 (free base)
- AOB3866
- DTXCID50102422
- EX-A535
- QCR-164
- SYN5163
- CHIR 99021 Hydrochloride Salt
- 6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile
- BCPP000285
- HMS3295O15
- BCP01901
- CHIR-99021 (CT99021)
- 2318AH
- ABP000490
- BDBM50325983
- HB1261
- HY-10182G
- HY-10182R
- MFCD12546133
- s1263
- WHO 11473
- ZINC29053046
- AKOS015904410
- AKOS026750421
- ACN-036844
- AM81240
- AN-1244
- BCP9000520
- CCG-269402
- CHIR-99021 (CT99021) HCl
- CID9956119
- CS-0181
- EBC-295041
- FD43329
- RL02837
- SB19266
- SDCCGSBI-0654265.P001
- CHIR-99021,CT99021
- CID 9956119
- CID:9956119
- NCGC00250379-01
- NCGC00250379-03
- NCGC00250379-09
- NCGC00250379-21
- AC-25532
- AK311166
- AS-16523
- HY-10182
- SC-62210
- SY016322
- SID:152186750
- 6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile
- 6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile
- C2943
- CHIR99021, >=98% (HPLC)
- CS-0615620
- FT-0700271
- 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- CHIR-99021 (CT99021)?
- CHIR-99021, 98% - 2MG 2mg
- J2.462.849C
- A10199
- A25048
- D12196
- S-7733
- [2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile
- C473711
- CHIR99021(CT99021)/CT-99021
- EN300-18520201
- GSK-3 Inhibitor XVI - CAS 252917-06-9
- BRD-K16189898-001-02-9
- BRD-K16189898-001-04-5
- BRD-K16189898-001-09-4
- BRD-K16189898-001-10-2
- BRD-K16189898-001-11-0
- BRD-K16189898-001-15-1
- BRD-K16189898-003-03-3
- I14-17021
- Q27075965
- 3-Pyridinecarbonitrile, 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl)amino)ethyl)amino)-
- 6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidaz
- B0084-462893
- CT99021, 252917-06-9
- 3-Pyridinecarbonitrile,6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-
- 6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-[2,4-Dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]NH}ethyl)NH]pyridine-3-CN
- 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile
- 6-[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile
- 6-[2-[4- -5- pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile
- InSolution GSK-3 Inhibitor XVI, CHIR99021 - CAS 252917-06-9
- 2-[[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazole-2-yl)-2-pyrimidinyl]amino]ethyl]amino]pyridine-5-carbonitrile
- 3-PYRIDINECARBONITRILE, 6-[[2-[[4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL]AMINO]ETHYL]AMINO]-
- 6-((2-((4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)pyridine-3-carbonitrile
- 6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl)NH)ethyl)NH)pyridine-3-CN
- 6-(2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethylamino)pyridine-3-carbonitrile
- 6-[(2-([4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl) -5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol -2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino }ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino)ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3 -carbonitrile
- 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
- 6-[(2-{[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino}ethyl)amino]nicotinonitrile
- 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazole-2-yl)-2-pyrimidinyl]amino]ethyl]amino]nicotinonitrile
- 6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-2-imidazolyl)-2-pyrimidinyl]amino]ethylamino]-3-pyridinecarbonitrile
- 6-{2-[4-(2,4-dichloro-phenyl)-5-(4-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile
- 6-{2-[4-(2,4-dichloro-phenyl)-5-(5-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile
- 65C
- 809-015-4
- CHIR-99021|||6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile